This week, we will discuss the best schedule for tapering steroids in adult patients with podocytopathies (MCD/FSGS).

KI Reports Community is the blog page affiliated with KI Reports and the ISN, representing a less restricted space where a variety of content is presented, including expert commentaries, article summa...

2025 was rich in successful stories. Here are the top 10 that impressed our audience.

In patients with dialysis-dependent acute kidney injury, a conservative dialysis strategy was evaluated in the LIBERATE-D trial. Could less be more? Join the discussion in #NephJC, but first, check ou...

This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.

En pacientes con lesión renal aguda en diálisis, se evaluó si una estrategia más conservadora impacta en la recuperación renal. ¿Será que menos es más? Únete a la discusión del ensayo clínico LIBERATE...

The NephJC shorts version of the Hypertension medication step-down in a nursing home population from NEJM

NephJC short on BICAR-ICU2

Atacicept, BAFF/APRIL inhibition in IgAN

This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.

We have a patient perspective on the new IgA Guidelines and what it means to live with IgA in these times.

Written by Elba MedinaReviewed by Brian Rifkin;Sophia AmbrusoToday, current methods for measuring kidney function, due to several critical limitations, need to be reimagined. In the reimagining Kidney...